A number of advancements have been made in algal technology in different
fields, such as medical, cosmetic, and pharmaceutical. Green algae
(Chlorophyta) are a group of photosynthetic organisms which live in both
aquatic and terrestrial environments. They are a potential source of
bioactive compounds for the treatment and prevention of a wide range of
infectious diseases caused by microorganisms. These compounds also possess
anti-inflammatory, antioxidant, anticoagulant, antitumor, and
immunomodulatory properties. A wide variety of bioactive compounds are
produced, including polysaccharides, which exhibit antimicrobial properties
capable of interfering with the cell walls, membranes, and nucleic acids of
microorganisms. Membrane fluidity, permeability, or integrity can be
affected by polyphenols and fatty acids which scavenge free radicals,
chelate metal ions, or disrupt enzymes and membranes. Proteins and peptides
form pores within the membranes which bind to specific receptors or inhibit
enzymes. Adaptation to adverse environmental conditions, such as temperature
extremes, photooxidation, salinity, or osmotic stress, results in the
formation of bioactive compounds by altering the physiological and
biochemical pathways of algae for the maintenance of cellular homeostasis.
With changing consumer preferences and an increase in the number of
resistant microorganisms, it is critical to seek novel antimicrobial
compounds from green algae. The search for novel bioactive compounds with
antimicrobial properties from green algae may serve as an alternative in the
light of increased drug resistance in microorganisms. However, in vitro and
in vivo evaluations of the safety, efficacy, and mechanism of action of the
antimicrobial compounds from green algae require more research. Providing an
overview of previous endeavours in this emerging field, this review provides
perspectives and a summary of the bioactive compounds responsible for the
antimicrobial properties of green algal extracts.